Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome

An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG

NCT00250250 ·Status: COMPLETED ·Phase: PHASE3

A Study of Zomacton in Children With Growth Hormone Deficiency

NCT00884000 ·Status: COMPLETED ·Phase: PHASE3

Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin

NCT00488124 ·Status: COMPLETED ·Phase: PHASE2

Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy

NCT00174187 ·Status: TERMINATED ·Phase: PHASE3

Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

NCT01734447 ·Status: COMPLETED ·Phase: PHASE4

Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy

NCT00174291 ·Status: TERMINATED ·Phase: PHASE3

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

NCT07221851 ·Status: RECRUITING ·Phase: PHASE3

Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary

NCT00174278 ·Status: COMPLETED ·Phase: PHASE3

Growth Retardation In Children With Special Pathological Conditions Or Disease

NCT00163215 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Children With Insufficient Secretion of Growth Hormone

NCT00271518 ·Status: UNKNOWN ·Phase: PHASE3

A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

NCT05894876 ·Status: TERMINATED

Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)

NCT02243852 ·Status: WITHDRAWN

Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature

NCT00121875 ·Status: TERMINATED

Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years

NCT00184691 ·Status: COMPLETED ·Phase: PHASE3

The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature

NCT01970800 ·Status: WITHDRAWN ·Phase: NA

Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

NCT04798690 ·Status: RECRUITING

Drug Use Investigation of Somatropin for GHD-ADULTS.

NCT00601419 ·Status: COMPLETED

Growth Response in Girls With Turner Syndrome

NCT01734486 ·Status: COMPLETED ·Phase: PHASE4

Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome

NCT01604161 ·Status: COMPLETED

Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency

NCT00837863 ·Status: UNKNOWN ·Phase: PHASE2

A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

NCT03255694 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9

NCT05723835 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children

NCT03290235 ·Status: UNKNOWN ·Phase: PHASE4

A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

NCT05330325 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature

NCT01248416 ·Status: COMPLETED ·Phase: PHASE3